Summary
According to APO Research, The global Nucleic Acids for Molecular Diagnosis market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Nucleic Acids for Molecular Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Nucleic Acids for Molecular Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Nucleic Acids for Molecular Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Nucleic Acids for Molecular Diagnosis include Agilent Technologies, Inc., Aji Bio-Pharma, Bio-synthesis Inc., Danaher Corporation, Eurofins Scientific SE, Integrated DNA Technologies, Kaneka Eurogentec S.A., L.G.C Biosearch Technologies and Merck KGaA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nucleic Acids for Molecular Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acids for Molecular Diagnosis.
The Nucleic Acids for Molecular Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acids for Molecular Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Nucleic Acids for Molecular Diagnosis Segment by Company
Agilent Technologies, Inc.
Aji Bio-Pharma
Bio-synthesis Inc.
Danaher Corporation
Eurofins Scientific SE
Integrated DNA Technologies
Kaneka Eurogentec S.A.
L.G.C Biosearch Technologies
Merck KGaA
metabion
QIAGEN
Thermo Fisher Scientific Inc.
Hongene
Synthgene
Nucleic Acids for Molecular Diagnosis Segment by Type
DNA Series
RNA Series
Nucleic Acids for Molecular Diagnosis Segment by Application
Early Cancer Screening
Genetic Diseases
Blood Screening
Genome Sequencing
Infectious Diseases
Other
Nucleic Acids for Molecular Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acids for Molecular Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acids for Molecular Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acids for Molecular Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nucleic Acids for Molecular Diagnosis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
- 1 Market Overview
- 2 Nucleic Acids for Molecular Diagnosis Market by Type
- 3 Nucleic Acids for Molecular Diagnosis Market by Application
- 4 Global Market Dynamics
- 5 Competitive Insights by Company
- 6 Company Profiles
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Concluding Insights
- 13 Appendix
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2020-2031)
1.4.1 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2020-2025)
1.4.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2026-2031)
1.5 Key Regions Nucleic Acids for Molecular Diagnosis Market Size (2020-2031)
1.5.1 North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.4 South America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
2.1 Type Introduction
2.1.1 DNA Series
2.1.2 RNA Series
2.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Type
2.2.1 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Type (2020-2031)
2.2.2 Global Nucleic Acids for Molecular Diagnosis Historic Market Size Review by Type (2020-2025)
2.2.3 Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Type (2026-2031)
2.3 Global Nucleic Acids for Molecular Diagnosis Market Size by Regions
2.3.1 North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.4 South America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
3.1 Type Introduction
3.1.1 Early Cancer Screening
3.1.2 Genetic Diseases
3.1.3 Blood Screening
3.1.4 Genome Sequencing
3.1.5 Infectious Diseases
3.1.6 Other
3.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Application
3.2.1 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Application (2020-2031)
3.2.2 Global Nucleic Acids for Molecular Diagnosis Historic Market Size Review by Application (2020-2025)
3.2.3 Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Application (2026-2031)
3.3 Global Nucleic Acids for Molecular Diagnosis Market Size by Regions
3.3.1 North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.4 South America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
4.1 Nucleic Acids for Molecular Diagnosis Industry Trends
4.2 Nucleic Acids for Molecular Diagnosis Industry Drivers
4.3 Nucleic Acids for Molecular Diagnosis Industry Opportunities and Challenges
4.4 Nucleic Acids for Molecular Diagnosis Industry Restraints
5.1 Global Top Players by Nucleic Acids for Molecular Diagnosis Revenue (2020-2025)
5.2 Global Nucleic Acids for Molecular Diagnosis Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Nucleic Acids for Molecular Diagnosis Key Company Headquarters & Area Served
5.4 Global Nucleic Acids for Molecular Diagnosis Company, Product Type & Application
5.5 Global Nucleic Acids for Molecular Diagnosis Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Nucleic Acids for Molecular Diagnosis Market CR5 and HHI
5.6.2 Global Top 5 and 10 Nucleic Acids for Molecular Diagnosis Players Market Share by Revenue in 2024
5.6.3 2024 Nucleic Acids for Molecular Diagnosis Tier 1, Tier 2, and Tier 3
6.1 Agilent Technologies, Inc.
6.1.1 Agilent Technologies, Inc. Comapny Information
6.1.2 Agilent Technologies, Inc. Business Overview
6.1.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.1.5 Agilent Technologies, Inc. Recent Developments
6.2 Aji Bio-Pharma
6.2.1 Aji Bio-Pharma Comapny Information
6.2.2 Aji Bio-Pharma Business Overview
6.2.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Portfolio
6.2.5 Aji Bio-Pharma Recent Developments
6.3 Bio-synthesis Inc.
6.3.1 Bio-synthesis Inc. Comapny Information
6.3.2 Bio-synthesis Inc. Business Overview
6.3.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.3.5 Bio-synthesis Inc. Recent Developments
6.4 Danaher Corporation
6.4.1 Danaher Corporation Comapny Information
6.4.2 Danaher Corporation Business Overview
6.4.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Portfolio
6.4.5 Danaher Corporation Recent Developments
6.5 Eurofins Scientific SE
6.5.1 Eurofins Scientific SE Comapny Information
6.5.2 Eurofins Scientific SE Business Overview
6.5.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Portfolio
6.5.5 Eurofins Scientific SE Recent Developments
6.6 Integrated DNA Technologies
6.6.1 Integrated DNA Technologies Comapny Information
6.6.2 Integrated DNA Technologies Business Overview
6.6.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
6.6.5 Integrated DNA Technologies Recent Developments
6.7 Kaneka Eurogentec S.A.
6.7.1 Kaneka Eurogentec S.A. Comapny Information
6.7.2 Kaneka Eurogentec S.A. Business Overview
6.7.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.7.5 Kaneka Eurogentec S.A. Recent Developments
6.8 L.G.C Biosearch Technologies
6.8.1 L.G.C Biosearch Technologies Comapny Information
6.8.2 L.G.C Biosearch Technologies Business Overview
6.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
6.8.5 L.G.C Biosearch Technologies Recent Developments
6.9 Merck KGaA
6.9.1 Merck KGaA Comapny Information
6.9.2 Merck KGaA Business Overview
6.9.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Product Portfolio
6.9.5 Merck KGaA Recent Developments
6.10 metabion
6.10.1 metabion Comapny Information
6.10.2 metabion Business Overview
6.10.3 metabion Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 metabion Nucleic Acids for Molecular Diagnosis Product Portfolio
6.10.5 metabion Recent Developments
6.11 QIAGEN
6.11.1 QIAGEN Comapny Information
6.11.2 QIAGEN Business Overview
6.11.3 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 QIAGEN Nucleic Acids for Molecular Diagnosis Product Portfolio
6.11.5 QIAGEN Recent Developments
6.12 Thermo Fisher Scientific Inc.
6.12.1 Thermo Fisher Scientific Inc. Comapny Information
6.12.2 Thermo Fisher Scientific Inc. Business Overview
6.12.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.12.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.12.5 Thermo Fisher Scientific Inc. Recent Developments
6.13 Hongene
6.13.1 Hongene Comapny Information
6.13.2 Hongene Business Overview
6.13.3 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.13.4 Hongene Nucleic Acids for Molecular Diagnosis Product Portfolio
6.13.5 Hongene Recent Developments
6.14 Synthgene
6.14.1 Synthgene Comapny Information
6.14.2 Synthgene Business Overview
6.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Product Portfolio
6.14.5 Synthgene Recent Developments
7.1 North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
7.3 North America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
8.1 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
8.3 Europe Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
9.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
9.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
10.1 South America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
10.3 South America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
11.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
11.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook